Interventions to minimize blood loss in very preterm infants - A systematic review and meta-analysis

Forskningsoutput: TidskriftsbidragÖversiktsartikel


Blood loss in the first days of life has been associated with increased morbidity and mortality in very preterm infants. In this systematic review we included randomized controlled trials comparing the effects of interventions to preserve blood volume in the infant from birth, reduce the need for sampling, or limit the blood sampled. Mortality and major neurodevelopmental disabilities were the primary outcomes. Included studies underwent risk of bias-assessment and data extraction by two review authors independently. We used risk ratio or mean difference to evaluate the treatment effect and meta-analysis for pooled results. The certainty of evidence was assessed using GRADE. We included 31 trials enrolling 3,759 infants. Twenty-five trials were pooled in the comparison delayed cord clamping or cord milking vs. immediate cord clamping or no milking. Increasing placental transfusion resulted in lower mortality during the neonatal period (RR 0.51, 95% CI 0.26 to 1.00; participants = 595; trials = 5; I2 = 0%, moderate certainty of evidence) and during first hospitalization (RR 0.70, 95% CI 0.51, 0.96; 10 RCTs, participants = 2,476, low certainty of evidence). The certainty of evidence was very low for the other primary outcomes of this review. The six remaining trials compared devices to monitor glucose levels (three trials), blood sampling from the umbilical cord or from the placenta vs. blood sampling from the infant (2 trials), and devices to reintroduce the blood after analysis vs. conventional blood sampling (1 trial); the certainty of evidence was rated as very low for all outcomes in these comparisons. Increasing placental transfusion at birth may reduce mortality in very preterm infants; However, extremely limited evidence is available to assess the effects of other interventions to reduce blood loss after birth. In future trials, infants could be randomized following placental transfusion to different blood saving approaches. Trial registration: PROSPERO CRD42020159882.


Enheter & grupper
Externa organisationer
  • Danube University Krems
  • Karl Landsteiner University of Health Sciences
  • Poznan University of Medical Sciences
  • Federal University of Minas Gerais
  • Medical College of Wisconsin
  • Skåne University Hospital
  • Hospital das Clínicas da Universidade Federal de Minas Gerais
  • University College London
  • Cochrane Sweden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Pediatrik
TidskriftPLoS ONE
Utgåva nummer2 February
StatusPublished - 2021
Peer review utfördJa